Clinical Trials
2 trialsNCT07274449 2025-12-10
NK
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2 Active not recruiting
NCT02694822 2025-03-17
AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy
Agenus Inc.
Phase 1/2 Completed